At the same time, with an initial hope to identify new therapeutic target for treatment of CO-induced depression and given the potential role of MAPK in such disorder, the present study also determined the blood MAPK3 transcript among patients with depression and characterized the role of MAPK3 in a mouse model of CO-induced depression. This evidence concerns the gene MAPK3 and depressive symptom measurement.